APA
Paparin J., Amador A., Badaroux E., Bot S., Caillet C., Convard T., Da Costa D., Dukhan D., Griffe L., Griffon J., LaColla M., Leroy F., Liuzzi M., Giulia Loi A., McCarville J., Mascia V., Milhau J., Onidi L., Pierra C., Rahali R., Rosinosky E., Sais E., Seifer M., Surleraux D., Standring D. & Dousson C. B. (20170821). Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor. : Bioorganic & medicinal chemistry letters.
Chicago
Paparin Jean-Laurent, Amador Agnès, Badaroux Eric, Bot Stéphanie, Caillet Catherine, Convard Thierry, Da Costa Daniel, Dukhan David, Griffe Ludovic, Griffon Jean-François, LaColla Massimiliano, Leroy Frédéric, Liuzzi Michel, Giulia Loi Anna, McCarville Joe, Mascia Valeria, Milhau Julien, Onidi Loredana, Pierra Claire, Rahali Rachid, Rosinosky Elodie, Sais Efisio, Seifer Maria, Surleraux Dominique, Standring David and Dousson Cyril B. 20170821. Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor. : Bioorganic & medicinal chemistry letters.
Harvard
Paparin J., Amador A., Badaroux E., Bot S., Caillet C., Convard T., Da Costa D., Dukhan D., Griffe L., Griffon J., LaColla M., Leroy F., Liuzzi M., Giulia Loi A., McCarville J., Mascia V., Milhau J., Onidi L., Pierra C., Rahali R., Rosinosky E., Sais E., Seifer M., Surleraux D., Standring D. and Dousson C. B. (20170821). Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor. : Bioorganic & medicinal chemistry letters.
MLA
Paparin Jean-Laurent, Amador Agnès, Badaroux Eric, Bot Stéphanie, Caillet Catherine, Convard Thierry, Da Costa Daniel, Dukhan David, Griffe Ludovic, Griffon Jean-François, LaColla Massimiliano, Leroy Frédéric, Liuzzi Michel, Giulia Loi Anna, McCarville Joe, Mascia Valeria, Milhau Julien, Onidi Loredana, Pierra Claire, Rahali Rachid, Rosinosky Elodie, Sais Efisio, Seifer Maria, Surleraux Dominique, Standring David and Dousson Cyril B. Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor. : Bioorganic & medicinal chemistry letters. 20170821.